The Growing Importance of Antimicrobial Susceptibility Testing in Healthcare

-

Antimicrobial susceptibility testing (AST) is a laboratory procedure used to determine which antibiotics will be most effective in treating a particular bacterial infection. The test involves exposing the bacteria to a range of antibiotics to see which ones are able to inhibit or kill the growth of the organism.

The global antimicrobial susceptibility testing market is expected to reach USD 4.7 billion by 2027, growing at a CAGR of 5.5% during the forecast period (2022-2027). The market growth can be attributed to the increasing prevalence of infectious diseases, rising healthcare expenditure, and growing demand for new and advanced antimicrobial susceptibility testing techniques.

Factors Driving the Antimicrobial Susceptibility Testing Market

◉Rising Prevalence of Infectious Diseases

The increasing prevalence of infectious diseases such as pneumonia, tuberculosis, and urinary tract infections is one of the key factors driving the antimicrobial susceptibility testing market. According to the World Health Organization, tuberculosis is one of the top 10 causes of death worldwide and the leading cause from a single infectious agent. In addition, the emergence of antibiotic-resistant strains of bacteria has further increased the demand for advanced antimicrobial susceptibility testing techniques.

◉Growing Healthcare Expenditure

As the global population continues to grow and age, healthcare expenditure is expected to increase. According to the World Health Organization, global healthcare expenditure is projected to reach USD 18.28 trillion by 2040, up from USD 7.72 trillion in 2015. This is expected to drive the demand for antimicrobial susceptibility testing, as healthcare providers seek to reduce the cost of treating infectious diseases by using more effective antibiotics.

◉Technological Advancements in Antimicrobial Susceptibility Testing

Recent advancements in technology have led to the development of new and advanced antimicrobial susceptibility testing techniques. For example, the use of microfluidics, biosensors, and digital imaging technologies has enabled the development of rapid and accurate antimicrobial susceptibility testing systems. These new technologies are expected to drive the growth of the antimicrobial susceptibility testing market in the coming years.

◉Increasing Focus on Preventive Healthcare

Preventive healthcare is becoming increasingly important as healthcare providers seek to reduce the burden of infectious diseases on the healthcare system. Antimicrobial susceptibility testing plays a critical role in preventive healthcare, as it allows healthcare providers to identify antibiotic-resistant strains of bacteria before they become a significant public health concern.

Challenges Facing the Antimicrobial Susceptibility Testing Market

◉Regulatory Challenges

Antimicrobial susceptibility testing is subject to regulatory oversight in many countries, which can create challenges for companies seeking to develop and market new testing products. The regulatory approval process can be lengthy and expensive, which can limit the availability of new and advanced testing technologies.

North America  to register major growth in the market during the forecast period

North America microcatheter market is anticipated to register the highest growth over the forecast period of 2022 to 2027. North America accounted for the largest share of 35.4% of the antimicrobial susceptibility testing market in 2022. This market is projected to reach USD 1.6 billion by 2027 from USD 1.2 billion in 2022, at a CAGR of 5.3% during the forecast period. The large share of North America can be attributed due to the growth in antibiotic resistance prevalence, the existence of important actors, an increase in healthcare spending, technological developments, and an increase in government activities in the area. Nonetheless, due to a rise in the region's population generally and rising investments in the healthcare industry, Asia-Pacific is expected to experience significant development.

Realted Links

https://www.marketsandmarkets.com/Market-Reports/antimicrobial-susceptibility-testing-market-206359984.html

https://www.marketsandmarkets.com/PressReleases/antimicrobial-susceptibility-testing.asp

https://www.prnewswire.com/news-releases/antimicrobial-susceptibility-testing-market-worth-4-7-billion--marketsandmarkets-301759332.html

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more